FDA staff focus on Onyx cancer drug's side effects
(Reuters) - U.S. drug reviewers said the serious heart, lung and liver side effects of Onyx Pharmaceuticals Inc's carfilzomib drug may outweigh the experimental drug's benefits for patients with a type of blood cancer. JUMP
Celebrating 29 years of marriage in December '17. After over 7 years of remission, Dom's Multiple Myeloma (Cancer of the blood plasma cells- attributed to Agent Orange Exposure while Dom served in Vietnam) has returned. Much of this blog concentrates on our adventure leading up to a Stem Cell Transplant, his remission, and our new adventure.